These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 24158015)

  • 1. A stereoselective approach to peptidomimetic BACE1 inhibitors.
    Butini S; Gabellieri E; Brindisi M; Giovani S; Maramai S; Kshirsagar G; Guarino E; Brogi S; La Pietra V; Giustiniano M; Marinelli L; Novellino E; Campiani G; Cappelli A; Gemma S
    Eur J Med Chem; 2013; 70():233-47. PubMed ID: 24158015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of bicyclic acetals as Beta Secretase (BACE1) inhibitors.
    Innocenti R; Lenci E; Menchi G; Pupi A; Trabocchi A
    Bioorg Med Chem; 2017 Oct; 25(19):5077-5083. PubMed ID: 28359674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tripeptidic BACE1 inhibitors devised by in-silico conformational structure-based design.
    Hamada Y; Tagad HD; Nishimura Y; Ishiura S; Kiso Y
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1130-5. PubMed ID: 22178553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishing the relationship between in vitro potency, pharmacokinetic, and pharmacodynamic parameters in a series of orally available, hydroxyethylamine-derived β-secretase inhibitors.
    Wood S; Wen PH; Zhang J; Zhu L; Luo Y; Babu-Khan S; Chen K; Pham R; Esmay J; Dineen TA; Kaller MR; Weiss MM; Hitchcock SA; Citron M; Zhong W; Hickman D; Williamson T
    J Pharmacol Exp Ther; 2012 Nov; 343(2):460-7. PubMed ID: 22911925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel peptidomimetics as BACE-1 inhibitors: synthesis, molecular modeling, and biological studies.
    Butini S; Gabellieri E; Brindisi M; Casagni A; Guarino E; Huleatt PB; Relitti N; La Pietra V; Marinelli L; Giustiniano M; Novellino E; Campiani G; Gemma S
    Bioorg Med Chem Lett; 2013 Jan; 23(1):85-9. PubMed ID: 23218605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New pyrazolyl and thienyl aminohydantoins as potent BACE1 inhibitors: exploring the S2' region.
    Malamas MS; Erdei J; Gunawan I; Barnes K; Hui Y; Johnson M; Robichaud A; Zhou P; Yan Y; Solvibile W; Turner J; Fan KY; Chopra R; Bard J; Pangalos MN
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5164-70. PubMed ID: 21835615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From fragment screening to in vivo efficacy: optimization of a series of 2-aminoquinolines as potent inhibitors of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1).
    Cheng Y; Judd TC; Bartberger MD; Brown J; Chen K; Fremeau RT; Hickman D; Hitchcock SA; Jordan B; Li V; Lopez P; Louie SW; Luo Y; Michelsen K; Nixey T; Powers TS; Rattan C; Sickmier EA; St Jean DJ; Wahl RC; Wen PH; Wood S
    J Med Chem; 2011 Aug; 54(16):5836-57. PubMed ID: 21707077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice.
    Meredith JE; Thompson LA; Toyn JH; Marcin L; Barten DM; Marcinkeviciene J; Kopcho L; Kim Y; Lin A; Guss V; Burton C; Iben L; Polson C; Cantone J; Ford M; Drexler D; Fiedler T; Lentz KA; Grace JE; Kolb J; Corsa J; Pierdomenico M; Jones K; Olson RE; Macor JE; Albright CF
    J Pharmacol Exp Ther; 2008 Aug; 326(2):502-13. PubMed ID: 18499745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship study of BACE1 inhibitors possessing a chelidonic or 2,6-pyridinedicarboxylic scaffold at the P(2) position.
    Hamada Y; Suzuki K; Nakanishi T; Sarma D; Ohta H; Yamaguchi R; Yamasaki M; Hidaka K; Ishiura S; Kiso Y
    Bioorg Med Chem Lett; 2014 Jan; 24(2):618-23. PubMed ID: 24360554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Structural Modification of BACE1 Inhibitors.
    Gu T; Wu WY; Dong ZX; Yu SP; Sun Y; Zhong Y; Lu YT; Li NG
    Molecules; 2016 Dec; 22(1):. PubMed ID: 28025519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbazole-containing arylcarboxamides as BACE1 inhibitors.
    Bertini S; Asso V; Ghilardi E; Granchi C; Manera C; Minutolo F; Saccomanni G; Bortolato A; Mason J; Moro S; Macchia M
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6657-61. PubMed ID: 21986588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Secretase (BACE1)-inhibiting C-methylrotenoids from Abronia nana suspension cultures.
    Park SH; Yang EJ; Kim SI; Song KS
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2945-8. PubMed ID: 24835197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of quinazolinone-based hydrazones with potential use in Alzheimer's disease.
    Haghighijoo Z; Firuzi O; Hemmateenejad B; Emami S; Edraki N; Miri R
    Bioorg Chem; 2017 Oct; 74():126-133. PubMed ID: 28780149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational restriction approach to BACE1 inhibitors II: SAR study of the isocytosine derivatives fixed with a cis-cyclopropane ring.
    Yonezawa S; Yamakawa H; Muto C; Hosono M; Yamamoto T; Hattori K; Sakagami M; Togame H; Tanaka Y; Nakano T; Takemoto H; Arisawa M; Shuto S
    Bioorg Med Chem Lett; 2013 May; 23(10):2912-5. PubMed ID: 23562056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of thiophene dihydroisoquinolines as novel BACE1 inhibitors.
    Xu YZ; Yuan S; Bowers S; Hom RK; Chan W; Sham HL; Zhu YL; Beroza P; Pan H; Brecht E; Yao N; Lougheed J; Yan J; Tam D; Ren Z; Ruslim L; Bova MP; Artis DR
    Bioorg Med Chem Lett; 2013 May; 23(10):3075-80. PubMed ID: 23570791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Substituted-thio-N-(4-substituted-thiazol/1H-imidazol-2-yl)acetamides as BACE1 inhibitors: Synthesis, biological evaluation and docking studies.
    Yan G; Hao L; Niu Y; Huang W; Wang W; Xu F; Liang L; Wang C; Jin H; Xu P
    Eur J Med Chem; 2017 Sep; 137():462-475. PubMed ID: 28624701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular docking based virtual screening of natural compounds as potential BACE1 inhibitors: 3D QSAR pharmacophore mapping and molecular dynamics analysis.
    Kumar A; Roy S; Tripathi S; Sharma A
    J Biomol Struct Dyn; 2016; 34(2):239-49. PubMed ID: 25707809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrapeptides, as small-sized peptidic inhibitors; synthesis and their inhibitory activity against BACE1.
    Kakizawa T; Hidaka K; Hamada D; Yamaguchi R; Uemura T; Kitamura H; Tagad HD; Hamada T; Ziora Z; Hamada Y; Kimura T; Kiso Y
    J Pept Sci; 2010 Jun; 16(6):257-62. PubMed ID: 20474036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent and selective isophthalamide S2 hydroxyethylamine inhibitors of BACE1.
    Kortum SW; Benson TE; Bienkowski MJ; Emmons TL; Prince DB; Paddock DJ; Tomasselli AG; Moon JB; LaBorde A; TenBrink RE
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3378-83. PubMed ID: 17434734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and SAR analysis of potent BACE1 inhibitors: Possible lead drug candidates for Alzheimer's disease.
    Tarazi H; Odeh RA; Al-Qawasmeh R; Yousef IA; Voelter W; Al-Tel TH
    Eur J Med Chem; 2017 Jan; 125():1213-1224. PubMed ID: 27871037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.